45.41

6.08% -2.94

Edgewise Therapeutics Inc (EWTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$48.35

Aprire:

$48.09

Volume 24 ore:

1.07M

Relative Volume:

0.76

Capitalizzazione di mercato:

$4.89B

Reddito:

Utile/perdita netta:

$-176.01M

Rapporto P/E:

-27.34

EPS:

-1.661

Flusso di cassa netto:

$-148.97M

1 W Prestazione:

+14.79%

1M Prestazione:

+37.94%

6M Prestazione:

+82.37%

1 anno Prestazione:

+227.40%

Intervallo 1D:

$43.81

$48.13

Intervallo di 1 settimana:

$39.27

$48.40

Portata 52W:

$12.30

$48.40

Edgewise Therapeutics Inc Stock (EWTX) Company Profile

Nome

Edgewise Therapeutics Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

720-262-7002

Indirizzo

1715 38TH ST, BOULDER

Dipendente

154

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

EWTX's Discussions on Twitter

Compare EWTX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EWTX Edgewise Therapeutics Inc	45.41	4.89B	0	-176.01M	-148.97M	-1.661
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-25	Iniziato	Goldman	Neutral
2025-07-30	Iniziato	Raymond James	Strong Buy
2025-06-30	Iniziato	H.C. Wainwright	Buy
2025-04-30	Iniziato	Guggenheim	Buy
2025-04-02	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2025-03-07	Iniziato	Scotiabank	Sector Outperform
2025-01-22	Iniziato	Stifel	Hold
2024-11-22	Iniziato	Evercore ISI	Outperform
2024-03-07	Iniziato	Piper Sandler	Overweight
2023-05-01	Iniziato	Truist	Buy
2022-08-25	Downgrade	Goldman	Neutral → Sell
2022-04-13	Iniziato	RBC Capital Mkts	Outperform
2022-01-28	Iniziato	Goldman	Neutral

Mostra tutto

Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie

Jul 11, 2026

Is Edgewise Therapeutics (EWTX) on the Cusp of a Breakthrough Year - Kavout | AI

Jul 11, 2026

Jul 10, 2026

Edgewise Therapeutics Stock Rides A 5-Day Winning Streak To A 23% Gain - Trefis

Jul 10, 2026

Jul 09, 2026

Oppenheimer Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $51 - Moomoo

Jul 09, 2026

CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits

Jul 09, 2026

Oppenheimer Initiates Edgewise Therapeutics at Outperform - Moomoo

Jul 09, 2026

EWTX Initiated Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus

Jul 09, 2026

Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says - Moomoo

Jul 09, 2026

Oppenheimer initiates Edgewise Therapeutics stock with outperform rating - Investing.com

Jul 09, 2026

Jul 08, 2026

Price to book forward of Edgewise Therapeutics, Inc. – NASDAQ:EWTX - TradingView

Jul 08, 2026

Edgewise Therapeutics stock hits all-time high at 43.96 USD - Investing.com UK

Jul 08, 2026

Edgewise Therapeutics stock hits all-time high at 43.96 USD By Investing.com - Investing.com South Africa

Jul 08, 2026

Price to earnings forward of Edgewise Therapeutics, Inc. – NASDAQ:EWTX - TradingView

Jul 08, 2026

Jul 07, 2026

Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline - AOL.com

Jul 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Jul 07, 2026

(EWTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Jul 07, 2026

Jul 06, 2026

Guggenheim Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $51 - Moomoo

Jul 06, 2026

Guggenheim raises Edgewise Therapeutics stock price target on Servier deal By Investing.com - Investing.com Canada

Jul 06, 2026

Jul 03, 2026

EWTXEdgewise Therapeutics Inc Options - Finviz

Jul 03, 2026

Jul 02, 2026

Edgewise Therapeutics(EWTX.US) Officer Sells US$7.88 Million in Common Stock - Moomoo

Jul 02, 2026

Edgewise Therapeutics chief scientific officer Alan Russell sells $7.88m By Investing.com - Investing.com South Africa

Jul 02, 2026

Edgewise Therapeutics chief scientific officer Alan Russell sells $7.88m - Investing.com

Jul 02, 2026

Form 4 Edgewise Therapeutics Inc For: 2 July By Investing.com - Investing.com Canada

Jul 02, 2026

Edgewise Therapeutics (EWTX) CSO exercises 200K options and sells 200K shares - Stock Titan

Jul 02, 2026

Jul 01, 2026

Form 4 Edgewise Therapeutics Inc For: 1 July By Investing.com - Investing.com India

Jul 01, 2026

Director Jonathan Fox of Edgewise Therapeutics (EWTX) receives 319-share stock grant - Stock Titan

Jul 01, 2026

[144] Edgewise Therapeutics, Inc. SEC Filing - Stock Titan

Jul 01, 2026

Form 144 | Edgewise Therapeutics(EWTX.US) Director Proposes to Sell 8.13 Million in Common Stocks - Moomoo

Jul 01, 2026

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire

Jul 01, 2026

Edgewise lures 2 new employees with 16,500 stock options - Stock Titan

Jul 01, 2026

Jun 29, 2026

Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now? - Insider Monkey

Jun 29, 2026

Jun 28, 2026

EWTX Stock Hits Record High – Why Servier Is Shelling Out $2.65B For Edgewise’s Muscular Dystrophy Business - Stocktwits

Jun 28, 2026

Jun 26, 2026